Products for Research Use Only
RegisterLogin

FSLLRY-NH2

CAT: 0804-HY-P1260-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P1260-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
FSLLRY-NH2 is a protease-activated receptor 2 (PAR2) inhibitor[1].
CAS Number
245329-02-6
UNSPSC
12352209
Hazard Statement
H302, H315, H319
Target
Protease Activated Receptor (PAR)
Type
Peptides
Related Pathways
GPCR/G Protein
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/fsllry-nh2.html
Purity
99.39
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
OC1=CC=C(C=C1)C[C@@H](C(N)=O)NC([C@H](CCCNC(N)=N)NC([C@H](CC(C)C)NC([C@H](CC(C)C)NC([C@H](CO)NC([C@H](CC2=CC=CC=C2)N)=O)=O)=O)=O)=O
Molecular Formula
C39H60N10O8
Molecular Weight
796.96
Precautions
H302, H315, H319
References & Citations
[1]Umut Ocak, et al. FSLLRY-NH2 Improves Neurological Outcome After Cardiac Arrest in Rats. Turk Neurosurg. 2020;30 (2) :244-251.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)
Scientific Category
Peptides
Clinical Information
No Development Reported
Isoform
PAR2
Citation 01
Biomolecules. 2025 Feb 1;15 (2) :208.|Brain Behav Immun. 2024 Jun 12:120:403-412.|Cell Signal. 2024 Aug 20:111355.|J Immunother Cancer. 2025 Jul 13;13 (7) :e010898.|Res Sq. 2024 Sep 04.|BMC Musculoskelet Disord. 2022 May 30;23 (1) :514.

Chemical Information

Fsllry-NH2
CAS Number245329-02-6
PubChem CID73352412
IUPAC Name(2S)-N-[(2S)-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanamide
Molecular FormulaC39H60N10O8
Molecular Weight797.0
XLogP0.6
Topological Polar Surface Area319
Hydrogen Bond Donor Count11
Hydrogen Bond Acceptor Count10
Rotatable Bond Count24
Heavy Atom Count57
Formal Charge0
Complexity1330
SMILES
CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC2=CC=CC=C2)N
InChI
InChI=1S/C39H60N10O8/c1-22(2)17-30(36(55)45-28(11-8-16-44-39(42)43)35(54)46-29(33(41)52)20-25-12-14-26(51)15-13-25)47-37(56)31(18-23(3)4)48-38(57)32(21-50)49-34(53)27(40)19-24-9-6-5-7-10-24/h5-7,9-10,12-15,22-23,27-32,50-51H,8,11,16-21,40H2,1-4H3,(H2,41,52)(H,45,55)(H,46,54)(H,47,56)(H,48,57)(H,49,53)(H4,42,43,44)/t27-,28-,29-,30-,31-,32-/m0/s1
InChIKey
KMSCNWHRNILNRJ-JNRWAQIZSA-N
Chemical Structure
2D Structure
2D structure of Fsllry-NH2
CAS: 245329-02-6
CID: 73352412
Formula: C39H60N10O8
MW: 797.0
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight797.0
XLogP30.6
Hydrogen Bond Donor Count11
Hydrogen Bond Acceptor Count10
Rotatable Bond Count24
Exact Mass796.45955891
Monoisotopic Mass796.45955891
Topological Polar Surface Area319 Ų
Heavy Atom Count57
Formal Charge0
Complexity1330
Isotope Atom Count0
Defined Atom Stereocenter Count6
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Related Products

CatalogName
HY-138523NH2-PEG3500-NH2
HY-W339437NH2-C3-PEG2-NH2
HY-W451406A-01NH2-PEG-NH2 (MW 5000)
HY-W451406DNH2-PEG-NH2 (MW 10000)
HY-W451406C-01NH2-PEG-NH2 (MW 2000)
HY-W451406BNH2-PEG-NH2 (MW 1000)
HY-128931NH2-Ph-C4-acid-NH2-Me
HY-148872-01Thalidomide-5-NH2-C8-NH2 (TFA)
HY-115454GB111-NH2
HY-P3591YMRF-NH2

Alternative Products

CatalogName
MBS5763902FSLLRY-NH2
A22849-5FSLLRY-NH2 5mg
A22849-1FSLLRY-NH2 1mg
S9915-25mgFSLLRY-NH2 TFA
A22849-25FSLLRY-NH2 25mg
A22849-10FSLLRY-NH2 10mg

Popular Products